255 related articles for article (PubMed ID: 20530685)
1. Low molecular weight cyclin E overexpression shortens mitosis, leading to chromosome missegregation and centrosome amplification.
Bagheri-Yarmand R; Biernacka A; Hunt KK; Keyomarsi K
Cancer Res; 2010 Jun; 70(12):5074-84. PubMed ID: 20530685
[TBL] [Abstract][Full Text] [Related]
2. Cyclin E deregulation impairs mitotic progression through premature activation of Cdc25C.
Bagheri-Yarmand R; Nanos-Webb A; Biernacka A; Bui T; Keyomarsi K
Cancer Res; 2010 Jun; 70(12):5085-95. PubMed ID: 20530684
[TBL] [Abstract][Full Text] [Related]
3. Cyclin E amplification, over-expression, and relapse-free survival in HER-2-positive primary breast cancer.
Luhtala S; Staff S; Tanner M; Isola J
Tumour Biol; 2016 Jul; 37(7):9813-23. PubMed ID: 26810187
[TBL] [Abstract][Full Text] [Related]
4. Tumor-specific low molecular weight forms of cyclin E induce genomic instability and resistance to p21, p27, and antiestrogens in breast cancer.
Akli S; Zheng PJ; Multani AS; Wingate HF; Pathak S; Zhang N; Tucker SL; Chang S; Keyomarsi K
Cancer Res; 2004 May; 64(9):3198-208. PubMed ID: 15126360
[TBL] [Abstract][Full Text] [Related]
5. Targeting low molecular weight cyclin E (LMW-E) in breast cancer.
Nanos-Webb A; Jabbour NA; Multani AS; Wingate H; Oumata N; Galons H; Joseph B; Meijer L; Hunt KK; Keyomarsi K
Breast Cancer Res Treat; 2012 Apr; 132(2):575-88. PubMed ID: 21695458
[TBL] [Abstract][Full Text] [Related]
6. Induction of centrosome amplification and chromosome instability in human bladder cancer cells by p53 mutation and cyclin E overexpression.
Kawamura K; Izumi H; Ma Z; Ikeda R; Moriyama M; Tanaka T; Nojima T; Levin LS; Fujikawa-Yamamoto K; Suzuki K; Fukasawa K
Cancer Res; 2004 Jul; 64(14):4800-9. PubMed ID: 15256449
[TBL] [Abstract][Full Text] [Related]
7. Specific overexpression of cyclin E·CDK2 in early preinvasive and primary breast tumors in female ACI rats induced by estrogen.
Weroha SJ; Lingle WL; Hong Y; Li SA; Li JJ
Horm Cancer; 2010 Feb; 1(1):34-43. PubMed ID: 21761349
[TBL] [Abstract][Full Text] [Related]
8. Low-molecular-weight cyclin E can bypass letrozole-induced G1 arrest in human breast cancer cells and tumors.
Akli S; Bui T; Wingate H; Biernacka A; Moulder S; Tucker SL; Hunt KK; Keyomarsi K
Clin Cancer Res; 2010 Feb; 16(4):1179-90. PubMed ID: 20145171
[TBL] [Abstract][Full Text] [Related]
9. Low-molecular-weight cyclin E deregulates DNA replication and damage repair to promote genomic instability in breast cancer.
Li M; Tsavachidis S; Wang F; Bui T; Nguyen TDT; Luo L; Multani AS; Bondy ML; Hunt KK; Keyomarsi K
Oncogene; 2022 Dec; 41(50):5331-5346. PubMed ID: 36344674
[TBL] [Abstract][Full Text] [Related]
10. Centrosome amplification induces high grade features and is prognostic of worse outcomes in breast cancer.
Denu RA; Zasadil LM; Kanugh C; Laffin J; Weaver BA; Burkard ME
BMC Cancer; 2016 Jan; 16():47. PubMed ID: 26832928
[TBL] [Abstract][Full Text] [Related]
11. Low-Molecular-Weight Cyclin E in Human Cancer: Cellular Consequences and Opportunities for Targeted Therapies.
Caruso JA; Duong MT; Carey JPW; Hunt KK; Keyomarsi K
Cancer Res; 2018 Oct; 78(19):5481-5491. PubMed ID: 30194068
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of the low molecular weight cyclin E in transgenic mice induces metastatic mammary carcinomas through the disruption of the ARF-p53 pathway.
Akli S; Van Pelt CS; Bui T; Multani AS; Chang S; Johnson D; Tucker S; Keyomarsi K
Cancer Res; 2007 Aug; 67(15):7212-22. PubMed ID: 17671189
[TBL] [Abstract][Full Text] [Related]
13. Low molecular weight cyclin E is specific in breast cancer and is associated with mechanisms of tumor progression.
Wingate H; Puskas A; Duong M; Bui T; Richardson D; Liu Y; Tucker SL; Van Pelt C; Meijer L; Hunt K; Keyomarsi K
Cell Cycle; 2009 Apr; 8(7):1062-8. PubMed ID: 19305161
[TBL] [Abstract][Full Text] [Related]
14. Detection of low molecular weight derivatives of cyclin E1 is a function of cyclin E1 protein levels in breast cancer.
Spruck C; Sun D; Fiegl H; Marth C; Mueller-Holzner E; Goebel G; Widschwendter M; Reed SI
Cancer Res; 2006 Jul; 66(14):7355-60. PubMed ID: 16849587
[TBL] [Abstract][Full Text] [Related]
15. Cyclin E2 induces genomic instability by mechanisms distinct from cyclin E1.
Caldon CE; Sergio CM; Burgess A; Deans AJ; Sutherland RL; Musgrove EA
Cell Cycle; 2013 Feb; 12(4):606-17. PubMed ID: 23324395
[TBL] [Abstract][Full Text] [Related]
16. Deregulation of the centrosome cycle and the origin of chromosomal instability in cancer.
Lingle WL; Lukasiewicz K; Salisbury JL
Adv Exp Med Biol; 2005; 570():393-421. PubMed ID: 18727509
[TBL] [Abstract][Full Text] [Related]
17. Ccne1 Overexpression Causes Chromosome Instability in Liver Cells and Liver Tumor Development in Mice.
Aziz K; Limzerwala JF; Sturmlechner I; Hurley E; Zhang C; Jeganathan KB; Nelson G; Bronk S; Fierro Velasco RO; van Deursen EJ; O'Brien DR; Kocher JA; Youssef SA; van Ree JH; de Bruin A; van den Bos H; Spierings DCJ; Foijer F; van de Sluis B; Roberts LR; Gores GJ; Li H; van Deursen JM
Gastroenterology; 2019 Jul; 157(1):210-226.e12. PubMed ID: 30878468
[TBL] [Abstract][Full Text] [Related]
18. Cyclin E deregulation promotes loss of specific genomic regions.
Teixeira LK; Wang X; Li Y; Ekholm-Reed S; Wu X; Wang P; Reed SI
Curr Biol; 2015 May; 25(10):1327-33. PubMed ID: 25959964
[TBL] [Abstract][Full Text] [Related]
19. Pin1 regulates centrosome duplication, and its overexpression induces centrosome amplification, chromosome instability, and oncogenesis.
Suizu F; Ryo A; Wulf G; Lim J; Lu KP
Mol Cell Biol; 2006 Feb; 26(4):1463-79. PubMed ID: 16449657
[TBL] [Abstract][Full Text] [Related]
20. Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.
Yeow ZY; Lambrus BG; Marlow R; Zhan KH; Durin MA; Evans LT; Scott PM; Phan T; Park E; Ruiz LA; Moralli D; Knight EG; Badder LM; Novo D; Haider S; Green CM; Tutt ANJ; Lord CJ; Chapman JR; Holland AJ
Nature; 2020 Sep; 585(7825):447-452. PubMed ID: 32908313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]